Payden & Rygel’s Johnson & Johnson JNJ Stock Holding History

Payden & Rygel’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15M	Hold	61,400	–	–	1.16%	34
2025 Q4	$12.7M	Sell	61,400 -3,500	-5%	-$692K	0.88%	42
2025 Q3	$12M	Hold	64,900	–	–	1%	47
2025 Q2	$9.91M	Hold	64,900	–	–	0.82%	60
2025 Q1	$10.8M	Buy	64,900 +27,900	+75%	+$4.37M	0.92%	57
2024 Q4	$5.35M	Sell	37,000 -6,800	-16%	-$1.05M	0.46%	70
2024 Q3	$7.1M	Hold	43,800	–	–	0.55%	67
2024 Q2	$6.4M	Sell	43,800 -47,100	-52%	-$7M	0.52%	67
2024 Q1	$14.4M	Buy	90,900 +12,600	+16%	+$2.01M	0.68%	60
2023 Q4	$12.3M	Hold	78,300	–	–	0.85%	62
2023 Q3	$12.2M	Sell	78,300 -1,700	-2%	-$281K	0.83%	56
2023 Q2	$13.2M	Sell	80,000 -43,400	-35%	-$7M	0.94%	51
2023 Q1	$19.1M	Buy	123,400 +5,400	+5%	+$872K	1.13%	40
2022 Q4	$20.8M	Hold	118,000	–	–	1.11%	47
2022 Q3	$19.3M	Buy	118,000 +2,800	+2%	+$474K	1.13%	44
2022 Q2	$20.4M	Hold	115,200	–	–	1.23%	37
2022 Q1	$20.4M	Sell	115,200 -55,100	-32%	-$9.38M	1.03%	56
2021 Q4	$29.1M	Hold	170,300	–	–	1.35%	29
2021 Q3	$27.5M	Buy	170,300 +6,300	+4%	+$1.07M	1.43%	27
2021 Q2	$27M	Sell	164,000 -800	-0.5%	-$132K	1.29%	33
2021 Q1	$27.1M	Buy	164,800 +3,200	+2%	+$518K	1.26%	40
2020 Q4	$25.4M	Hold	161,600	–	–	1.3%	40
2020 Q3	$24.1M	Buy	161,600 +45,400	+39%	+$6.72M	1.43%	34
2020 Q2	$16.3M	Hold	116,200	–	–	1.04%	54
2020 Q1	$15.2M	Buy	116,200 +6,900	+6%	+$979K	1.1%	46
2019 Q4	$15.9M	Hold	109,300	–	–	1%	48
2019 Q3	$14.1M	Sell	109,300 -83,300	-43%	-$11M	0.96%	54
2019 Q2	$26.8M	Buy	192,600 +1,100	+0.6%	+$152K	1.84%	19
2019 Q1	$26.8M	Buy	191,500 +99,600	+108%	+$13.3M	1.95%	18
2018 Q4	$11.9M	Buy	91,900 +81,700	+801%	+$11.4M	0.96%	55
2018 Q3	$1.41M	Hold	10,200	–	–	0.11%	69
2018 Q2	$1.24M	Hold	10,200	–	–	0.1%	70
2018 Q1	$1.31M	Hold	10,200	–	–	0.11%	74
2017 Q4	$1.43M	Hold	10,200	–	–	0.12%	74
2017 Q3	$1.33M	Sell	10,200 -153,500	-94%	-$20.3M	0.13%	76
2017 Q2	$21.7M	Buy	163,700 +3,200	+2%	+$408K	1.89%	13
2017 Q1	$20M	Hold	160,500	–	–	1.82%	16
2016 Q4	$18.5M	Buy	160,500 +13,400	+9%	+$1.55M	1.71%	22
2016 Q3	$17.4M	Hold	147,100	–	–	1.74%	25
2016 Q2	$17.8M	Hold	147,100	–	–	2.03%	18
2016 Q1	$15.9M	Buy	147,100 +45,516	+45%	+$4.71M	1.94%	22
2015 Q4	$10.4M	Buy	101,584 +19,184	+23%	+$1.93M	1.38%	33
2015 Q3	$7.69M	Buy	82,400 +57,600	+232%	+$5.57M	1.11%	48
2015 Q2	$2.42M	Hold	24,800	–	–	0.32%	68
2015 Q1	$2.5M	Sell	24,800 -45,100	-65%	-$4.59M	0.33%	70
2014 Q4	$7.31M	Buy	69,900 +6,100	+10%	+$643K	1.4%	35
2014 Q3	$6.8M	Buy	63,800 +12,100	+23%	+$1.25M	1.35%	34
2014 Q2	$5.41M	Sell	51,700 -700	-1%	-$70.8K	1.37%	32
2014 Q1	$5.15M	Hold	52,400	–	–	2.01%	16
2013 Q4	$4.8M	Hold	52,400	–	–	1.63%	21
2013 Q3	$4.54M	Sell	52,400 -3,800	-7%	-$341K	1.62%	17
2013 Q2	$4.83M	Buy	+56,200	New	+$4.77M	1.88%	12

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Payden & Rygel's JNJ Position: Q1 2026 in Review

Payden & Rygel held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 61,400 shares worth $15M. The position accounts for 1.16% of the portfolio, ranked #34.

Payden & Rygel first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.1M in Q4 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Payden & Rygel held 61,400 shares of Johnson & Johnson worth $15M as of Q1 2026.
Payden & Rygel left its Johnson & Johnson share count unchanged in Q1 2026.
Johnson & Johnson made up 1.16% of Payden & Rygel's portfolio in Q1 2026, its #34 holding.
Payden & Rygel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
Payden & Rygel's Johnson & Johnson position peaked at $29.1M in Q4 2021.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.